[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Premature Ejaculation Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

January 2024 | 104 pages | ID: GDF31F8A336DEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Premature Ejaculation Treatment market size was valued at USD 2946.9 million in 2023 and is forecast to a readjusted size of USD 5319.8 million by 2030 with a CAGR of 8.8% during review period.

Common treatment options for premature ejaculation include behavioral techniques, topical anesthetics, medications and counseling. Keep in mind that it might take time to find the treatment or combination of treatments that will work for you. Behavioral treatment plus drug therapy might be the most effective course.

Global Premature Ejaculation Treatment key players include Pfizer, Novartis, Eli Lilly, Johnson & Johnson, etc.

The Global Info Research report includes an overview of the development of the Premature Ejaculation Treatment industry chain, the market status of Hospital (Antidepressants(SSRIs), Phosphodiesterase-5 Inhibitors), Retail Pharmacy (Antidepressants(SSRIs), Phosphodiesterase-5 Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Premature Ejaculation Treatment.

Regionally, the report analyzes the Premature Ejaculation Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Premature Ejaculation Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Premature Ejaculation Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Premature Ejaculation Treatment industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antidepressants(SSRIs), Phosphodiesterase-5 Inhibitors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Premature Ejaculation Treatment market.

Regional Analysis: The report involves examining the Premature Ejaculation Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Premature Ejaculation Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Premature Ejaculation Treatment:

Company Analysis: Report covers individual Premature Ejaculation Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Premature Ejaculation Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Distribution Channel (Hospital, Retail Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Premature Ejaculation Treatment. It assesses the current state, advancements, and potential future developments in Premature Ejaculation Treatment areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Premature Ejaculation Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Premature Ejaculation Treatment market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of value.

Market segment by Type
  • Antidepressants(SSRIs)
  • Phosphodiesterase-5 Inhibitors
  • Topical Anesthetics
  • Analgesics
  • Other Treatment
Market segment by Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Other
Market segment by players, this report covers
  • Pfizer
  • Novartis
  • Eli Lilly
  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer
  • Menarini
  • Teva
  • Sunrise Pharma
  • Regent Pacific
  • Torrent Pharma
  • Vivus
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Premature Ejaculation Treatment product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Premature Ejaculation Treatment, with revenue, gross margin and global market share of Premature Ejaculation Treatment from 2019 to 2024.

Chapter 3, the Premature Ejaculation Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Premature Ejaculation Treatment market forecast, by regions, type and distribution channel, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Premature Ejaculation Treatment.

Chapter 13, to describe Premature Ejaculation Treatment research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Premature Ejaculation Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Premature Ejaculation Treatment by Type
  1.3.1 Overview: Global Premature Ejaculation Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Global Premature Ejaculation Treatment Consumption Value Market Share by Type in 2023
  1.3.3 Antidepressants(SSRIs)
  1.3.4 Phosphodiesterase-5 Inhibitors
  1.3.5 Topical Anesthetics
  1.3.6 Analgesics
  1.3.7 Other Treatment
1.4 Global Premature Ejaculation Treatment Market by Distribution Channel
  1.4.1 Overview: Global Premature Ejaculation Treatment Market Size by Distribution Channel: 2019 Versus 2023 Versus 2030
  1.4.2 Hospital
  1.4.3 Retail Pharmacy
  1.4.4 Online Pharmacy
  1.4.5 Other
1.5 Global Premature Ejaculation Treatment Market Size & Forecast
1.6 Global Premature Ejaculation Treatment Market Size and Forecast by Region
  1.6.1 Global Premature Ejaculation Treatment Market Size by Region: 2019 VS 2023 VS 2030
  1.6.2 Global Premature Ejaculation Treatment Market Size by Region, (2019-2030)
  1.6.3 North America Premature Ejaculation Treatment Market Size and Prospect (2019-2030)
  1.6.4 Europe Premature Ejaculation Treatment Market Size and Prospect (2019-2030)
  1.6.5 Asia-Pacific Premature Ejaculation Treatment Market Size and Prospect (2019-2030)
  1.6.6 South America Premature Ejaculation Treatment Market Size and Prospect (2019-2030)
  1.6.7 Middle East and Africa Premature Ejaculation Treatment Market Size and Prospect (2019-2030)

2 COMPANY PROFILES

2.1 Pfizer
  2.1.1 Pfizer Details
  2.1.2 Pfizer Major Business
  2.1.3 Pfizer Premature Ejaculation Treatment Product and Solutions
  2.1.4 Pfizer Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis
  2.2.1 Novartis Details
  2.2.2 Novartis Major Business
  2.2.3 Novartis Premature Ejaculation Treatment Product and Solutions
  2.2.4 Novartis Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Novartis Recent Developments and Future Plans
2.3 Eli Lilly
  2.3.1 Eli Lilly Details
  2.3.2 Eli Lilly Major Business
  2.3.3 Eli Lilly Premature Ejaculation Treatment Product and Solutions
  2.3.4 Eli Lilly Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 Johnson & Johnson
  2.4.1 Johnson & Johnson Details
  2.4.2 Johnson & Johnson Major Business
  2.4.3 Johnson & Johnson Premature Ejaculation Treatment Product and Solutions
  2.4.4 Johnson & Johnson Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Johnson & Johnson Recent Developments and Future Plans
2.5 GlaxoSmithKline
  2.5.1 GlaxoSmithKline Details
  2.5.2 GlaxoSmithKline Major Business
  2.5.3 GlaxoSmithKline Premature Ejaculation Treatment Product and Solutions
  2.5.4 GlaxoSmithKline Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Bayer
  2.6.1 Bayer Details
  2.6.2 Bayer Major Business
  2.6.3 Bayer Premature Ejaculation Treatment Product and Solutions
  2.6.4 Bayer Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Bayer Recent Developments and Future Plans
2.7 Menarini
  2.7.1 Menarini Details
  2.7.2 Menarini Major Business
  2.7.3 Menarini Premature Ejaculation Treatment Product and Solutions
  2.7.4 Menarini Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Menarini Recent Developments and Future Plans
2.8 Teva
  2.8.1 Teva Details
  2.8.2 Teva Major Business
  2.8.3 Teva Premature Ejaculation Treatment Product and Solutions
  2.8.4 Teva Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Teva Recent Developments and Future Plans
2.9 Sunrise Pharma
  2.9.1 Sunrise Pharma Details
  2.9.2 Sunrise Pharma Major Business
  2.9.3 Sunrise Pharma Premature Ejaculation Treatment Product and Solutions
  2.9.4 Sunrise Pharma Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Sunrise Pharma Recent Developments and Future Plans
2.10 Regent Pacific
  2.10.1 Regent Pacific Details
  2.10.2 Regent Pacific Major Business
  2.10.3 Regent Pacific Premature Ejaculation Treatment Product and Solutions
  2.10.4 Regent Pacific Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Regent Pacific Recent Developments and Future Plans
2.11 Torrent Pharma
  2.11.1 Torrent Pharma Details
  2.11.2 Torrent Pharma Major Business
  2.11.3 Torrent Pharma Premature Ejaculation Treatment Product and Solutions
  2.11.4 Torrent Pharma Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.11.5 Torrent Pharma Recent Developments and Future Plans
2.12 Vivus
  2.12.1 Vivus Details
  2.12.2 Vivus Major Business
  2.12.3 Vivus Premature Ejaculation Treatment Product and Solutions
  2.12.4 Vivus Premature Ejaculation Treatment Revenue, Gross Margin and Market Share (2019-2024)
  2.12.5 Vivus Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Premature Ejaculation Treatment Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
  3.2.1 Market Share of Premature Ejaculation Treatment by Company Revenue
  3.2.2 Top 3 Premature Ejaculation Treatment Players Market Share in 2023
  3.2.3 Top 6 Premature Ejaculation Treatment Players Market Share in 2023
3.3 Premature Ejaculation Treatment Market: Overall Company Footprint Analysis
  3.3.1 Premature Ejaculation Treatment Market: Region Footprint
  3.3.2 Premature Ejaculation Treatment Market: Company Product Type Footprint
  3.3.3 Premature Ejaculation Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Premature Ejaculation Treatment Consumption Value and Market Share by Type (2019-2024)
4.2 Global Premature Ejaculation Treatment Market Forecast by Type (2025-2030)

5 MARKET SIZE SEGMENT BY DISTRIBUTION CHANNEL

5.1 Global Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel (2019-2024)
5.2 Global Premature Ejaculation Treatment Market Forecast by Distribution Channel (2025-2030)

6 NORTH AMERICA

6.1 North America Premature Ejaculation Treatment Consumption Value by Type (2019-2030)
6.2 North America Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2030)
6.3 North America Premature Ejaculation Treatment Market Size by Country
  6.3.1 North America Premature Ejaculation Treatment Consumption Value by Country (2019-2030)
  6.3.2 United States Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  6.3.3 Canada Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  6.3.4 Mexico Premature Ejaculation Treatment Market Size and Forecast (2019-2030)

7 EUROPE

7.1 Europe Premature Ejaculation Treatment Consumption Value by Type (2019-2030)
7.2 Europe Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2030)
7.3 Europe Premature Ejaculation Treatment Market Size by Country
  7.3.1 Europe Premature Ejaculation Treatment Consumption Value by Country (2019-2030)
  7.3.2 Germany Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  7.3.3 France Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  7.3.4 United Kingdom Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  7.3.5 Russia Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  7.3.6 Italy Premature Ejaculation Treatment Market Size and Forecast (2019-2030)

8 ASIA-PACIFIC

8.1 Asia-Pacific Premature Ejaculation Treatment Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2030)
8.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Region
  8.3.1 Asia-Pacific Premature Ejaculation Treatment Consumption Value by Region (2019-2030)
  8.3.2 China Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  8.3.3 Japan Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  8.3.4 South Korea Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  8.3.5 India Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  8.3.6 Southeast Asia Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  8.3.7 Australia Premature Ejaculation Treatment Market Size and Forecast (2019-2030)

9 SOUTH AMERICA

9.1 South America Premature Ejaculation Treatment Consumption Value by Type (2019-2030)
9.2 South America Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2030)
9.3 South America Premature Ejaculation Treatment Market Size by Country
  9.3.1 South America Premature Ejaculation Treatment Consumption Value by Country (2019-2030)
  9.3.2 Brazil Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  9.3.3 Argentina Premature Ejaculation Treatment Market Size and Forecast (2019-2030)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Premature Ejaculation Treatment Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2030)
10.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Country
  10.3.1 Middle East & Africa Premature Ejaculation Treatment Consumption Value by Country (2019-2030)
  10.3.2 Turkey Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  10.3.3 Saudi Arabia Premature Ejaculation Treatment Market Size and Forecast (2019-2030)
  10.3.4 UAE Premature Ejaculation Treatment Market Size and Forecast (2019-2030)

11 MARKET DYNAMICS

11.1 Premature Ejaculation Treatment Market Drivers
11.2 Premature Ejaculation Treatment Market Restraints
11.3 Premature Ejaculation Treatment Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Premature Ejaculation Treatment Industry Chain
12.2 Premature Ejaculation Treatment Upstream Analysis
12.3 Premature Ejaculation Treatment Midstream Analysis
12.4 Premature Ejaculation Treatment Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Premature Ejaculation Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Premature Ejaculation Treatment Consumption Value by Distribution Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Global Premature Ejaculation Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Premature Ejaculation Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Premature Ejaculation Treatment Product and Solutions
Table 8. Pfizer Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Premature Ejaculation Treatment Product and Solutions
Table 13. Novartis Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Eli Lilly Company Information, Head Office, and Major Competitors
Table 16. Eli Lilly Major Business
Table 17. Eli Lilly Premature Ejaculation Treatment Product and Solutions
Table 18. Eli Lilly Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Eli Lilly Recent Developments and Future Plans
Table 20. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 21. Johnson & Johnson Major Business
Table 22. Johnson & Johnson Premature Ejaculation Treatment Product and Solutions
Table 23. Johnson & Johnson Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Johnson & Johnson Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Premature Ejaculation Treatment Product and Solutions
Table 28. GlaxoSmithKline Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. Bayer Company Information, Head Office, and Major Competitors
Table 31. Bayer Major Business
Table 32. Bayer Premature Ejaculation Treatment Product and Solutions
Table 33. Bayer Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bayer Recent Developments and Future Plans
Table 35. Menarini Company Information, Head Office, and Major Competitors
Table 36. Menarini Major Business
Table 37. Menarini Premature Ejaculation Treatment Product and Solutions
Table 38. Menarini Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Menarini Recent Developments and Future Plans
Table 40. Teva Company Information, Head Office, and Major Competitors
Table 41. Teva Major Business
Table 42. Teva Premature Ejaculation Treatment Product and Solutions
Table 43. Teva Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Teva Recent Developments and Future Plans
Table 45. Sunrise Pharma Company Information, Head Office, and Major Competitors
Table 46. Sunrise Pharma Major Business
Table 47. Sunrise Pharma Premature Ejaculation Treatment Product and Solutions
Table 48. Sunrise Pharma Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Sunrise Pharma Recent Developments and Future Plans
Table 50. Regent Pacific Company Information, Head Office, and Major Competitors
Table 51. Regent Pacific Major Business
Table 52. Regent Pacific Premature Ejaculation Treatment Product and Solutions
Table 53. Regent Pacific Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Regent Pacific Recent Developments and Future Plans
Table 55. Torrent Pharma Company Information, Head Office, and Major Competitors
Table 56. Torrent Pharma Major Business
Table 57. Torrent Pharma Premature Ejaculation Treatment Product and Solutions
Table 58. Torrent Pharma Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Torrent Pharma Recent Developments and Future Plans
Table 60. Vivus Company Information, Head Office, and Major Competitors
Table 61. Vivus Major Business
Table 62. Vivus Premature Ejaculation Treatment Product and Solutions
Table 63. Vivus Premature Ejaculation Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Vivus Recent Developments and Future Plans
Table 65. Global Premature Ejaculation Treatment Revenue (USD Million) by Players (2019-2024)
Table 66. Global Premature Ejaculation Treatment Revenue Share by Players (2019-2024)
Table 67. Breakdown of Premature Ejaculation Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Premature Ejaculation Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Premature Ejaculation Treatment Players
Table 70. Premature Ejaculation Treatment Market: Company Product Type Footprint
Table 71. Premature Ejaculation Treatment Market: Company Product Application Footprint
Table 72. Premature Ejaculation Treatment New Market Entrants and Barriers to Market Entry
Table 73. Premature Ejaculation Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Premature Ejaculation Treatment Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Premature Ejaculation Treatment Consumption Value Share by Type (2019-2024)
Table 76. Global Premature Ejaculation Treatment Consumption Value Forecast by Type (2025-2030)
Table 77. Global Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2024)
Table 78. Global Premature Ejaculation Treatment Consumption Value Forecast by Distribution Channel (2025-2030)
Table 79. North America Premature Ejaculation Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Premature Ejaculation Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 82. North America Premature Ejaculation Treatment Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 83. North America Premature Ejaculation Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Premature Ejaculation Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Premature Ejaculation Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Premature Ejaculation Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 88. Europe Premature Ejaculation Treatment Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 89. Europe Premature Ejaculation Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Premature Ejaculation Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 94. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 95. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Premature Ejaculation Treatment Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Premature Ejaculation Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Premature Ejaculation Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 100. South America Premature Ejaculation Treatment Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 101. South America Premature Ejaculation Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Premature Ejaculation Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 106. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 107. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Premature Ejaculation Treatment Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Premature Ejaculation Treatment Raw Material
Table 110. Key Suppliers of Premature Ejaculation Treatment Raw Materials

LIST OF FIGURES

Figure 1. Premature Ejaculation Treatment Picture
Figure 2. Global Premature Ejaculation Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Premature Ejaculation Treatment Consumption Value Market Share by Type in 2023
Figure 4. Antidepressants(SSRIs)
Figure 5. Phosphodiesterase-5 Inhibitors
Figure 6. Topical Anesthetics
Figure 7. Analgesics
Figure 8. Other Treatment
Figure 9. Global Premature Ejaculation Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel in 2023
Figure 11. Hospital Picture
Figure 12. Retail Pharmacy Picture
Figure 13. Online Pharmacy Picture
Figure 14. Other Picture
Figure 15. Global Premature Ejaculation Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Premature Ejaculation Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Premature Ejaculation Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 18. Global Premature Ejaculation Treatment Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Premature Ejaculation Treatment Consumption Value Market Share by Region in 2023
Figure 20. North America Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East and Africa Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 25. Global Premature Ejaculation Treatment Revenue Share by Players in 2023
Figure 26. Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 27. Global Top 3 Players Premature Ejaculation Treatment Market Share in 2023
Figure 28. Global Top 6 Players Premature Ejaculation Treatment Market Share in 2023
Figure 29. Global Premature Ejaculation Treatment Consumption Value Share by Type (2019-2024)
Figure 30. Global Premature Ejaculation Treatment Market Share Forecast by Type (2025-2030)
Figure 31. Global Premature Ejaculation Treatment Consumption Value Share by Distribution Channel (2019-2024)
Figure 32. Global Premature Ejaculation Treatment Market Share Forecast by Distribution Channel (2025-2030)
Figure 33. North America Premature Ejaculation Treatment Consumption Value Market Share by Type (2019-2030)
Figure 34. North America Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 35. North America Premature Ejaculation Treatment Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe Premature Ejaculation Treatment Consumption Value Market Share by Type (2019-2030)
Figure 40. Europe Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 41. Europe Premature Ejaculation Treatment Consumption Value Market Share by Country (2019-2030)
Figure 42. Germany Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 43. France Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 44. United Kingdom Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 45. Russia Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 46. Italy Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 47. Asia-Pacific Premature Ejaculation Treatment Consumption Value Market Share by Type (2019-2030)
Figure 48. Asia-Pacific Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 49. Asia-Pacific Premature Ejaculation Treatment Consumption Value Market Share by Region (2019-2030)
Figure 50. China Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 51. Japan Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 52. South Korea Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 53. India Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 54. Southeast Asia Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 55. Australia Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 56. South America Premature Ejaculation Treatment Consumption Value Market Share by Type (2019-2030)
Figure 57. South America Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 58. South America Premature Ejaculation Treatment Consumption Value Market Share by Country (2019-2030)
Figure 59. Brazil Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 60. Argentina Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 61. Middle East and Africa Premature Ejaculation Treatment Consumption Value Market Share by Type (2019-2030)
Figure 62. Middle East and Africa Premature Ejaculation Treatment Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 63. Middle East and Africa Premature Ejaculation Treatment Consumption Value Market Share by Country (2019-2030)
Figure 64. Turkey Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 65. Saudi Arabia Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 66. UAE Premature Ejaculation Treatment Consumption Value (2019-2030) & (USD Million)
Figure 67. Premature Ejaculation Treatment Market Drivers
Figure 68. Premature Ejaculation Treatment Market Restraints
Figure 69. Premature Ejaculation Treatment Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Premature Ejaculation Treatment in 2023
Figure 72. Manufacturing Process Analysis of Premature Ejaculation Treatment
Figure 73. Premature Ejaculation Treatment Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source


More Publications